Inspired by patients and families around the world, we are researching and developing therapies for rare genetic disorders with a lead candidate in #PraderWilliSyndrome currently under FDA regulatory review. To sign up for updates, visit www.soleno.life.
Investor insights
Funding rounds participated in
$50M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Funding rounds raised
Total raised
$50M
from 1 investors over 1 rounds
S
Soleno Therapeutics, Inc. raised $50M on January 17, 2025